Milena L Cavalcante, MD
Rheumatology · Clovis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- Graduated 2010
Offices
1 location · Dehesa Dermatology Inc · 5 clinicians in this group
Looking this up.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cavalcante’s office at (559) 307-9155 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
California Medical Board record
Licence A173007 · Current
Licensed to practise in California · since 2021 · expires 2027-06-30 · Universidade Federal DO Estado DO Rio De Janeiro (Unirio) School of Medicine and Surgery.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$372,173 in 2024
Medicaid paid $372,173 for 8,199 billed services this clinician did in 2024, up to 144 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,377 | $362,692 |
| Return visit (30+ min) | 1,995 | $7,648 |
| New patient visit (45+ min) | 398 | $883 |
| Short return visit (20+ min) | 262 | $848 |
| Arthrocentesis and injection of knee joint | 19 | $46 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 222 | $28 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 34 | $24 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 34 | $4 |
| Medication list documented in medical record (COA) | 1,549 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 1,549 | $0 |
| BODY MASS INDEX DOCD | 719 | $0 |
| Injection, methylprednisolone acetate, 1 mg | 41 | $0 |
| 2024 | 8,199 | 12 | 144 | $372,173 |
| 2023 | 7,703 | 12 | 127 | $322,933 |
| 2022 | 4,821 | 9 | 112 | $230,602 |
| 2021 | 851 | 11 | 52 | $52,957 |
| 2020 | 3,840 | 18 | 61 | $96,442 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,246 | $315,313 |
| Return visit (30+ min) | 1,493 | $4,385 |
| New patient visit (45+ min) | 413 | $2,028 |
| Short return visit (20+ min) | 220 | $623 |
| Short return visit | 146 | $308 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 12 | $98 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 225 | $87 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 52 | $78 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 55 | $13 |
| Medication list documented in medical record (COA) | 1,512 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 1,511 | $0 |
| BODY MASS INDEX DOCD | 818 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 906 | $224,803 |
| New patient visit (45+ min) | 400 | $2,216 |
| Return visit (30+ min) | 613 | $2,179 |
| Short return visit | 529 | $922 |
| Medication list documented in medical record (COA) | 906 | $452 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 35 | $25 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 35 | $4 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 915 | $0 |
| BODY MASS INDEX DOCD | 482 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 160 | $39,402 |
| Return visit (30+ min) | 159 | $11,910 |
| COMPREHENSIVE METABOLIC PANEL | 76 | $470 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 73 | $329 |
| Measurement of C-reactive protein | 83 | $236 |
| Complement; antigen, each component | 14 | $218 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 82 | $140 |
| Sedimentation rate, erythrocyte; automated | 84 | $125 |
| New patient visit (45+ min) | 77 | $69 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 29 | $35 |
| Short return visit (20+ min) | 14 | $24 |
2020
| Return visit (30+ min) | 559 | $46,152 |
| New patient visit (45+ min) | 283 | $33,717 |
| Extractable nuclear antigen, antibody to, any method (eg, nRNP, SS-A, SS-B, Sm, RNP, Sc170, J01), each antibody | 97 | $4,331 |
| COMPREHENSIVE METABOLIC PANEL | 353 | $2,090 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 354 | $1,563 |
| ANTINUCLEAR ANTIBODIES | 181 | $1,168 |
| Measurement of C-reactive protein | 392 | $1,154 |
| Complement; antigen, each component | 81 | $1,085 |
| Deoxyribonucleic acid (DNA) antibody; native or double stranded | 115 | $846 |
| Assay for cyclic citrullinated peptide (CCP) antibody | 124 | $812 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 470 | $809 |
| Short return visit (20+ min) | 12 | $705 |
Drugs they prescribed that Part D paid
$947,479
Pharmacies billed $947,479 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
856 generic and 236 brand-name prescriptions · $947,479 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 32 | $222,870 | $6,965 |
| Humira | 35 | $216,733 | $6,192 |
| Tremfya | 11 | $134,775 | $12,252 |
| Actemra Actpen | 24 | $79,721 | $3,322 |
| Orencia Clickject | 13 | $72,362 | $5,566 |
See all 20 drugs
| Enbrel Sureclick | 32 | $222,870 | $6,965 |
| Humira | 35 | $216,733 | $6,192 |
| Tremfya | 11 | $134,775 | $12,252 |
| Actemra Actpen | 24 | $79,721 | $3,322 |
| Orencia Clickject | 13 | $72,362 | $5,566 |
| Rasuvo | 35 | $18,360 | $525 |
| Hydroxychloroquine Sulfate | 192 | $7,088 | $37 |
| Methotrexate | 192 | $3,390 | $18 |
| Azathioprine | 50 | $2,326 | $47 |
| Mycophenolate Mofetil | 22 | $1,925 | $87 |
| Sulfasalazine | 56 | $1,203 | $21 |
| Leflunomide | 20 | $1,056 | $53 |
| Prednisone | 145 | $787 | $5 |
| Diclofenac | 30 | $528 | $18 |
| Baclofen | 14 | $450 | $32 |
| Cyclobenzaprine | 14 | $238 | $17 |
| Alendronate | 35 | $195 | $6 |
| Folic Acid | 37 | $190 | $5 |
| Allopurinol | 19 | $163 | $9 |
| Naproxen | 12 | $67 | $6 |
Year by year
| 2024 | 1,092 | 139 | None | 22% | $947,479 |
| 2023 | 909 | 125 | 0% (0) | 12% | $539,410 |
| 2022 | 409 | 76 | 0% (0) | None | $210,982 |
| 2021 | 352 | 133 | 6% (22) | None | $60,929 |
| 2020 | 874 | 161 | 2% (17) | None | $122,411 |
| 2017 | 270 | 47 | None | 32% | $100,097 |
| 2016 | 520 | 93 | 6% (29) | None | $117,930 |
| 2015 | 93 | 42 | 28% (26) | 14% | $6,081 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Tremfya | 12 | $178,421 | $14,868 |
| Humira(Cf) | 11 | $86,038 | $7,822 |
| Orencia Clickject | 11 | $63,063 | $5,733 |
| Hydroxychloroquine Sulfate | 191 | $7,781 | $41 |
| Methotrexate | 103 | $3,043 | $30 |
| Azathioprine | 38 | $2,805 | $74 |
| Mycophenolate Mofetil | 20 | $2,627 | $131 |
| Diclofenac | 81 | $2,344 | $29 |
| Leflunomide | 31 | $1,857 | $60 |
| Sulfasalazine | 63 | $986 | $16 |
| Prednisone | 161 | $925 | $6 |
| Alendronate | 32 | $516 | $16 |
| Allopurinol | 30 | $478 | $16 |
| Folic Acid | 22 | $45 | $2 |
2022: 10 drugs
| Humira | 17 | $107,829 | $6,343 |
| Hydroxychloroquine Sulfate | 96 | $5,287 | $55 |
| Diclofenac | 66 | $1,704 | $26 |
| Azathioprine | 26 | $1,480 | $57 |
| Methotrexate | 47 | $942 | $20 |
| Mycophenolate Mofetil | 11 | $614 | $56 |
| Sulfasalazine | 20 | $325 | $16 |
| Prednisone | 46 | $245 | $5 |
| Allopurinol | 16 | $194 | $12 |
| Alendronate | 14 | $32 | $2 |
2021: 4 drugs
| Hydroxychloroquine Sulfate | 92 | $5,596 | $61 |
| Methotrexate | 94 | $3,025 | $32 |
| Leflunomide | 12 | $915 | $76 |
| Prednisone | 59 | $722 | $12 |
2020: 7 drugs
| Hydroxychloroquine Sulfate | 259 | $14,353 | $55 |
| Methotrexate | 272 | $6,895 | $25 |
| Leflunomide | 21 | $1,765 | $84 |
| Prednisone | 151 | $1,426 | $9 |
| Diclofenac | 28 | $717 | $26 |
| Celecoxib | 13 | $332 | $26 |
| Allopurinol | 11 | $41 | $4 |
2017: 8 drugs
| Hydroxychloroquine Sulfate | 14 | $2,612 | $187 |
| Colcrys | 16 | $2,205 | $138 |
| Colchicine | 12 | $1,767 | $147 |
| Methotrexate | 35 | $1,644 | $47 |
| Voltaren | 12 | $1,234 | $103 |
| Allopurinol | 43 | $396 | $9 |
| Prednisone | 28 | $156 | $6 |
| Alendronate | 15 | $30 | $2 |
2016: 13 drugs
| Enbrel | 11 | $44,800 | $4,073 |
| Hydroxychloroquine Sulfate | 52 | $7,709 | $148 |
| Colcrys | 25 | $3,613 | $145 |
| Colchicine | 24 | $3,003 | $125 |
| Methotrexate | 65 | $2,937 | $45 |
| Voltaren | 14 | $1,188 | $85 |
| Allopurinol | 74 | $836 | $11 |
| Prednisone | 61 | $424 | $7 |
| Sulfasalazine | 11 | $250 | $23 |
| Gabapentin | 16 | $218 | $14 |
| Cyclobenzaprine | 16 | $160 | $10 |
| Naproxen | 12 | $141 | $12 |
| Meloxicam | 13 | $57 | $4 |
2015: 1 drug
| Prednisone | 13 | $74 | $6 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2024 | 3 | 3 | None | $152 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Incyte | Opzelura | $125 | 1 payment
|
See the published payment
| Incyte | Meals · 2025-10-09 | Opzelura | $125 |
See earlier years (2024)
2024: $152
| Aurinia Pharma U.S. | Lupkynis | $122 | 1 payment
|
| Abbvie | Rinvoq | $16 | 1 payment
|
| Genentech USA | Actemra | $14 | 1 payment
|
Professional record
- NPI
- 1225453467
- Licence
- CA 173007, OR MD191711California A173007: Current · expires 2027-06-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 213 N Amedeo Ln, Clovis, CA, 93611
- NPI first listed
- 2014-02-25
- NPI last updated
- 2021-07-27
- NPI record certified
- 2021-03-12
This is when the NPI record was last certified, not a medical board exam.